Sir,

In response to our report on *Scedosporium apiospermum* sinusitis in a patient following prolonged anti-TNFα therapy,\[[@ref1]\] Dr. Monika Matlani has brought to our notice about a case of *Scedosporium prolificans* osteomyelitis in an immunocompetent child. *Scedosporium* infection has been reported in both immunocompetent and immunocompromised subjects. However, *Scedosporium* is mostly an opportunistic fungus.

In recent years, an increasing number of cases of human disease with *S. apiospermum* have been reported, probably due to widespread use of corticosteroids, immunosuppressants, antineoplastics and broad-spectrum antibiotics. Thus, it is essential for dermatologists to be aware of clinical presentations and diagnosis of *Scedosporium* infection.

Cutaneous manifestations of *Scedosporium* infection are protean. In most cases, inoculation of spores in the cutaneous and subcutaneous tissues is due to penetrating trauma or surgery. *Scedosporium* spp. infections can present as papules, erythematous plaques, folliculitis, necrotic papules, cutaneous ulcers, nodules, subcutaneous abscesses, and ulcers in a sporotrichoid (lymphangitic) pattern, ecchymosis, and hemorrhagic bullae.\[[@ref2]--[@ref4]\] Thus, the cutaneous manifestations are nonspecific and can be misleading in respect to the underlying disease. In appropriate clinical scenario, specifically in immunocompromised patients, physicians need to be suspicious for *Scedosporium* and other opportunistic infections. On occasions, a specific diagnosis of *Scedosporium* infection may require repeated biopsies, specific fungal staining, and fungal culture.
